Trial Profile
Evaluation of the Bioavailability of Pramlintide.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Pramlintide (Primary)
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Amylin Pharmaceuticals
- 22 Aug 2012 New trial record